2-bromopalmitate inhibits PD-L1 palmitoylation to reduce PD-L1 surface level and in turn promotes antitumor immunity in the murine MC38 tumor model.36 On the other hand, upregulating PD-L1 surface level has also been shown to be beneficial under certain circumstances. The gene discussed is CD274; the disease is neoplasm.